Stada says acquisitions in 3.5-5 bln eur range, private equity tie-ups possible |
|
|
|
Published
:
Thu, 29 Mar 2007 13:02
|
FRANKFURT (AFX) - Stada Arzneimittel AG said it may be interested in acquisitions as large as Merck KGaA's generics unit, while co-operations with private equity firms are also an option to finance its expansion plans.Merck's generics unit, which is up for sale, has drawn bids between 3.8-5 bln eur according to the Wall Street Journal.'We can imagine a cooperation with private equity firms,' chief executive Hartmut Retzlaff said at the company's annual business results conference.The company is particularly interested in expanding in Eastern Europe and Turkey, chief financial officer Wolfgang Jeblonski stated.Asked whether Stada is specifically interested in Merck's generics unit, as previously reported, he said, 'We do not participate in market speculation'.patrizia.kokot@thomson.compk/mas/jlcCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Stada says had 'good start' to 2007, sales up 17 pct in Jan, Feb UPDATE 